Nuclera

About:

Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers.

Website: https://www.nuclera.com

Twitter/X: nuclera

Top Investors: Cambridge Innovation Capital, Verve Ventures, Future Planet Capital, Innovate UK, Elevage Medical Technologies

Description:

Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers. Nuclera's eProtein DiscoveryTM system allows scientists to rapidly produce and test proteins for drug discovery.

Total Funding Amount:

$146M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Cambridge, Cambridgeshire, United Kingdom

Founded Date:

2013-08-27

Contact Email:

hello(AT)nuclera.com

Founders:

Gordon McInroy, Jiahao Huang, Michael Chen

Number of Employees:

101-250

Last Funding Date:

2024-10-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai